Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Pateclizumab (Synonyms: RG7416, RG 7416, PRO283698, PRO 283698, MLTA3698A, MLTA 3698A)

Catalog No. T77366 Copy Product Info
🥰Excellent
Pateclizumab (MLTA3698A) is a humanized monoclonal antibody targeting lymphotoxin α (LTα), which can be used to study rheumatoid arthritis.

Pateclizumab

Copy Product Info
🥰Excellent
Catalog No. T77366
Synonyms RG7416, RG 7416, PRO283698, PRO 283698, MLTA3698A, MLTA 3698A

Pateclizumab (MLTA3698A) is a humanized monoclonal antibody targeting lymphotoxin α (LTα), which can be used to study rheumatoid arthritis.

Pateclizumab
Cas No. 1202526-59-7
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$415-In Stock
5 mg$1,245-In Stock
10 mg$1,992-In Stock
25 mg$3,386-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:96.96% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Pateclizumab (MLTA3698A) is a humanized monoclonal antibody targeting lymphotoxin α (LTα), which can be used to study rheumatoid arthritis.
In vitro
Pateclizumab is a human immunoglobulin G1 (IgG1) monoclonal antibody. By blocking the binding of Lα3 to TNFRII and Lα1β2 to Lβr, the IC50 was 0.29 nM and 0.31 nM, respectively. [1]
In vivo
In cynomolgus monkeys treated with pateclizumab (5, 15, 50 mg/kg), the ratio of fetal to maternal serum concentration was 0.73% on GD 50 and 61% on GD 139. Taking Pateclizumab between the 20th and 132nd days of gestation does not induce maternal or fetal developmental toxicity. [1]
SynonymsRG7416, RG 7416, PRO283698, PRO 283698, MLTA3698A, MLTA 3698A
Reactivity
Human
Verified Activity
Immobilized human TNFSF1/TNFb Protein (His) at 2 μg/mL can bind Pateclizumab. The EC50 is 0.01351 μg/mL.
verifiedActivity
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetTNFSF1/TNFb/ LT alpha
Chemical Properties
Molecular Weight144.9 kDa
Cas No.1202526-59-7
Antibody Information
IsotypeHuman IgG1 kappa
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Pateclizumab | purchase Pateclizumab | Pateclizumab cost | order Pateclizumab | Pateclizumab in vivo | Pateclizumab in vitro | Pateclizumab molecular weight